![Thomas King](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Thomas King
Vorsitzender bei
Concentric Analgesics, Inc.
Vermögen: 2 Mio $ am 31.05.2026
Profil
Thomas Braxton King is Executive Chairman at Concentric Analgesics, Inc. since 2018 and Director at Faraday Pharmaceuticals, Inc. since 2014.
Former roles include President, Chief Executive Officer & Director at Anesta Corp.
from 1997 to 2000; President, Chief Executive Officer, CFO & CAO at Alexza Pharmaceuticals, Inc. in 2016; President, Chief Executive Officer & Director at Cognetix, Inc. from 2002 to 2003; Chairman at Achieve Life Sciences, Inc. from 2024 to 2026; Chairman at Kinaset Therapeutics, Inc. from 2020 to 2026; Director at Orphan Medical, Inc. in 2007; Independent Director at VIVUS, Inc. from 2018 to 2020; Director at Achaogen, Inc.; Director at Faraday Pharmaceuticals, Inc. (Washington); Director at Symphony Allegro, Inc.; Independent Director at Satsuma Pharmaceuticals, Inc. from 2017 to 2023; Independent Director at TFF Pharmaceuticals, Inc. from 2023 to 2024.
Education includes an undergraduate degree from McPherson College in 1977 and an MBA from Kansas University School of Business.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 20.04.2026 | 315.142 ( 0,31 % ) | 2 Mio $ | 31.05.2026 |
Aktive Positionen von Thomas King
| Unternehmen | Position | Beginn |
|---|---|---|
Faraday Pharmaceuticals, Inc.
 Faraday Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics to treat ischemia-reperfusion injury | Direktor/Vorstandsmitglied | 01.01.2014 |
Concentric Analgesics, Inc.
 Concentric Analgesics, Inc. Packaged SoftwareTechnology Services Develops non-opioid therapeutics platform for pain management | Vorsitzender | 01.01.2018 |
Ehemalige bekannte Positionen von Thomas King
| Unternehmen | Position | Ende |
|---|---|---|
Kinaset Therapeutics, Inc.
 Kinaset Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops inhaled therapeutics for respiratory diseases | Vorsitzender | 30.06.2026 |
| ACHIEVE LIFE SCIENCES, INC. | Vorsitzender | 08.06.2026 |
| TFF PHARMACEUTICALS, INC. | Direktor/Vorstandsmitglied | 14.11.2024 |
| SATSUMA PHARMACEUTICALS, INC. | Direktor/Vorstandsmitglied | 08.06.2023 |
| VIVUS, INC. | Vorstandsvorsitzender | 30.04.2018 |
Ausbildung von Thomas King
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
53
Beziehungen ersten Grades
16
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 16 |
|---|---|
Anesta Corp.
 Anesta Corp. Pharmaceuticals: MajorHealth Technology Develops new pharmaceutical products for oral transmucosal drug administration | Health Technology |
Orphan Medical, Inc.
 Orphan Medical, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets pharmaceutical and health care products | Health Technology |
VIVUS, Inc.
 VIVUS, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops and commercializes next-generation therapies | Health Technology |
Achaogen, Inc.
 Achaogen, Inc. Pharmaceuticals: MajorHealth Technology Operates as a a biopharmaceutical company, which engages in the research, development, and commercialization of antibacterial treatments for multi-drug resistant (MDR) gram-negative infections | Health Technology |
Faraday Pharmaceuticals, Inc. (Washington)
 Faraday Pharmaceuticals, Inc. (Washington) Drugstore ChainsRetail Trade Develops small molecule drugs | Retail Trade |
Alexza Pharmaceuticals, Inc.
 Alexza Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies for the acute treatment of central nervous system conditions | Health Technology |
Cognetix, Inc.
 Cognetix, Inc. Drugstore ChainsRetail Trade Discovers and develops drugs | Retail Trade |
McPherson College
 McPherson College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Symphony Allegro, Inc.
 Symphony Allegro, Inc. Pharmaceuticals: MajorHealth Technology Manufactures biopharmaceutical drugs | Health Technology |
Kansas University School of Business
 Kansas University School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Faraday Pharmaceuticals, Inc.
Faraday Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics to treat ischemia-reperfusion injury | Health Technology |
Concentric Analgesics, Inc.
Concentric Analgesics, Inc. Packaged SoftwareTechnology Services Develops non-opioid therapeutics platform for pain management | Technology Services |
Satsuma Pharmaceuticals, Inc.
 Satsuma Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company for migraine and debilitating conditions | Health Technology |
Achieve Life Sciences, Inc.
 Achieve Life Sciences, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes cytisinicline for smoking cessation and nicotine addiction | Health Technology |
TFF Pharmaceuticals, Inc.
 TFF Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures inhaled dry powder drugs for the treatment of pulmonary diseases and conditions | Health Technology |
Kinaset Therapeutics, Inc.
Kinaset Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops inhaled therapeutics for respiratory diseases | Health Technology |
Wählen Sie MarketScreener 
